Related Experiment Video
Updated: Sep 1, 2025

07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
2.6K
Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.
1Independent Researcher, Istanbul, Turkey.
Cancer Management and Research
|August 12, 2022
Summary
Oxidative stress triggers complex signaling pathways involving c-Abl and CYLD. CYLD acts as both an oncoprotein and tumor suppressor, regulating NF-κB activity crucial for cellular homeostasis.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Signal Transduction
Background:
- Oxidative stress and DNA damage can activate TNF-R1 and c-Abl, promoting cytoplasmic translocation.
- Persistent cytoplasmic c-Abl is linked to cellular transformation.
- c-Abl's phosphorylation of OTULIN disrupts its interaction with LUBAC, initiating a signaling cascade.
Purpose of the Study:
- To elucidate the role of c-Abl, OTULIN, LUBAC, SPATA2, CYLD, and IKKβ in NF-κB activation following genotoxic stress.
- To investigate the dual role of CYLD as both an oncoprotein and tumor suppressor in cellular signaling.
- To understand the mechanism by which CYLD regulates NF-κB activity and cellular homeostasis.
Main Methods:
- Investigated molecular interactions including c-Abl-OTULIN, OTULIN-LUBAC, LUBAC-SPATA2, and SPATA2-CYLD.
- Analyzed the phosphorylation events on OTULIN (tyrosine 56) and CYLD (serine 568).
- Examined the activation of IKKβ and subsequent NF-κB transcriptional activity.
Main Results:
- c-Abl phosphorylates OTULIN, leading to LUBAC release and recruitment to the TNF-R1 complex.
- This facilitates SPATA2-CYLD interaction, crucial for IKKβ activation and NF-κB signaling.
- IKKβ-mediated phosphorylation of CYLD at serine 568 is essential for its deubiquitinating activity and termination of signaling.
Conclusions:
- CYLD exhibits dual activity, initiating NF-κB signaling as an oncoprotein and terminating it as a tumor suppressor.
- Failure in CYLD phosphorylation by IKKβ leads to sustained oncogenic activity and dysregulated NF-κB.
- This dysregulation disrupts cellular homeostasis, favoring transformation and potentially contributing to cancer development.
More Related Videos
Related Concept Videos
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Induced Pluripotent Stem Cells
4.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.3K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancers Originate from Somatic Mutations in a Single Cell
12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K

